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adult onset symmetrical pelvic and shoulder girdle weakness
and predominant lower motor neuron involvement, which
has been confirmed pathologically.3,4 In contrast, other FUS
mutations present more frequently with flail arm syndrome
or with typical limb or bulbar onset ALS. Our patient with
juvenile-onset ALS, an R521C missense mutation, and a flail
leg presentation represents an unusual combination. FUS
mutations should be assessed in young patients who present
with rapidly progressive flail leg syndrome, even in the
absence of upper motor neuron signs.
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AN UNUSUAL PRESENTATION FOR
SOD1-ALS: ISOLATED FACIAL DIPLEGIA
Approximately 20% of familial amyotrophic lateral scle-
rosis (fALS) cases are linked to mutations in the super-
oxide dismutase 1 gene (SOD1). More than 160
mutations have been reported.1–3
A 63-year-old man developed insidious onset of
lower facial weakness. The initial symptom was difficulty
speaking. One year later. he noticed difficulty smiling
and handling food in the mouth due to weakness in his
cheeks. No laterality of symptoms was reported, and
neurological examination showed no tongue or limb
involvement. Two years after onset, he noted progres-
sive left hand weakness and loss of dexterity. Examina-
tion demonstrated bilateral lower facial weakness and
atrophy, sparing the frontalis muscle. There were no
tongue fasciculations. Articulation was normal except
for labial consonants. There was a positive jaw jerk. The
remainder of the cranial nerve examination was nor-
mal. There was mild distal left upper extremity atrophy
and weakness. In the lower limbs, tone was increased,
but power was normal. Reflexes were brisk in all limbs.
The Hoffman sign was absent, and plantar reflexes
were extensor.
A first cousin on his father’s side died of ALS.
Blood tests and cerebrospinal fluid were unremark-
able. MRI scan of brain and spine were normal.
Electrodiagnostic studies supported a diagnosis of
motor neuronopathy. Needle examination revealed
chronic neurogenic changes in the face, widespread
and frequent polymorphic fasciculation potentials in
the limbs, less frequent fasciculation potentials in
the paraspinal and trapezius muscles, and very mild
and patchy neurogenic abnormalities in the limbs.
Nerve conduction studies were normal except for a
mild ulnar neuropathy at the left elbow. Central
motor conduction times showed prolonged latency
in the upper left limb. Sequencing of SOD1 revealed
a heterozygous T>C point mutation resulting in the
substitution of Isoleucine for Threonine at amino
acid 113 (Ile113Thr).
In the following 6 months, the patient developed
spasticity and widespread fasciculations in all limbs. He
did not develop emotional lability. He died 3 years after
symptom onset.
The Ile113Thr mutation was among the first SOD1
mutations described1 and is the third most common
SOD1 mutation.2 Its penetrance was shown to be low in
fALS families4 making it plausible that the proband’s
cousin, who died of ALS, also had this mutation and
that both the patient’s father and uncle were obligate
carriers who did not develop ALS (Figure 1). Previous
reports of the SOD1 Ile113Thr mutation indicate a
mean age of onset of 57.86 15.1 years and a disease
duration of 4.26 2.5 years, which are both compatible
with the described patient.5 This mutation has been
linked recently to a patient with ALS/FTD, another very
atypical finding for SOD1 ALS.6
In a previous report, a patient with the SOD1 A4V
mutation presented with facial diplegia, but this also
involved upper face muscles and was accompanied by
dysarthria, dysphagia, and unilateral vocal cord paraly-
sis.7 The striking feature of the patient reported here is
that the facial diplegia was the only finding for the first
2 years.
FIGURE 1. Pedigree of the family. Arrow identifies the proband.
The proband’s father and paternal uncle are potential obligate
carriers of the mutation. The proband’s father died of ischemic
heart disease at age 77 years. No information is available for
the proband’s paternal uncle.
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In summary, this atypical presentation for a common
SOD1 fALS mutation expands the known clinical spec-
trum of this mutation.
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INCLUSION BODY MYOPATHY WITH
PAGET DISEASE OF BONE AND
FRONTOTEMPORAL DEMENTIA
ASSOCIATED WITH A NOVEL G156S
MUTATION IN THE VCP GENE
Inclusion body myopathy (IBM) with Paget disease of
bone (PDB) and frontotemporal dementia (FTD)
(IBMPFD) is a progressive autosomal dominant multisys-
tem disorder affecting muscles, bones, and brain.
IBMPFD has been attributed to missense mutations in
the valosin-containing protein gene (VCP) on chromo-
some 9p13.3. We describe a patient with IBMPFD associ-
ated with a novel G156S mutation in VCP.
A 65-year-old Japanese man with no family history of
PDB, FTD, or myopathic disease was evaluated for a 9-
year history of progressive muscle weakness and a 1-year
history of irritability and difficulty recalling names of
friends. At age 40, he had presented with low back pain
and an elevated serum alkaline phosphatase level (750
U/L: normal 30–115). 99m Tc-methylene diphosphonate
bone scan showed abnormal accumulations in the skull,
spine, iliac bone, and right shoulder joint. An L2 verte-
bral biopsy revealed PDB. Neurological examination
revealed proximal-predominant muscle atrophy and
weakness in his extremities. His Mini-Mental State Exam-
ination and Frontal Assessment Battery scores were 26/
30 (normal range, >27/30) and 13/18 (normal range,
>14/18),1 respectively. The Wechsler Adult Intelligence
Scale-III revealed a decline in his verbal intelligence quo-
tient from 93 at age 63 to 59 at age 65, and in his per-
formance intelligence quotient from 115 at age 63 to 86
at age 65. Serum creatine kinase levels were normal.
Electromyography revealed myopathic features, and a
biopsy of the right tibialis anterior muscle revealed myo-
pathic changes with rimmed vacuoles (Fig. 1a). Brain
MRI showed bilateral frontotemporal lobe atrophy
(Supp. Fig. S1, which is available online), and 99m Tc-
methyl cysteinate-dimer single photon emission com-
puted tomography disclosed blood flow reduction in the
bilateral parietal and left temporal lobes.
A genomic study was approved by the Ethics Com-
mittee for Human Genome/Gene Analysis Research at
Kanazawa University Graduate School of Medical Scien-
ces, and informed consent was obtained from the
patient. Genomic DNA was isolated from blood. Muta-
tion screening was performed by direct sequencing of
PCR products of coding exons 2, 3, 5, and 6 of VCP,2
and a novel heterozygous base substitution was found in
exon 5: c.466G>A (p.G156S), as shown in Figure 1b.
This mutation was not observed in 100 healthy Japanese
control subjects.
Although more than half of the missense mutations in
VCP associated with IBMPFD have been reported to cluster
in the N-terminal hot spot, R155, in exon 5,3 this G156S
mutation is novel. The particular shape and charge distri-
bution within the cleft around R155 of VCP may be
FIGURE 1. (a) A biopsy from the tibialis anterior muscle shows
a rimmed vacuole (arrow) with myopathic change on hematoxy-
lin and eosin. (b) Sequence chromatogram of the c.466G>A
(p.G156S) mutation in exon 5 of the VCP.
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